Sézary综合征伴肾脏受累:一例病例报告
Sézary综合征是一种罕见侵袭性原发性皮肤T细胞淋巴瘤的白血病变异型。本文报告一例66岁男性因肾功能恶化就诊,通过皮肤和肾脏活检的聚合酶链反应证实克隆性T细胞群与外周血一致,经阿仑单抗治疗后肾功能显著改善并成功接受异基因干细胞移植。
要点
- Sézary综合征可累及肾脏导致肾功能下降,活检有助于诊断。
- 皮肤和肾脏活检PCR证实克隆性T细胞群与外周血一致。
- 阿仑单抗治疗后肾功能显著改善,后续异基因干细胞移植成功。
核心结论
- Sézary综合征伴肾脏受累是肾功能下降的罕见原因,活检在疑似病例中具有重要作用。
研究设计与样本
- 单例病例报告:66岁男性,因肾功能恶化由皮肤科转诊。
主要发现
- 皮肤和肾脏活检基因组DNA的PCR证实克隆性T细胞群与外周血分离的群体一致。
- 初始阿仑单抗治疗后肾功能显著改善,随后成功接受异基因干细胞移植。
临床怎么用
- 对疑似Sézary综合征且肾功能下降的患者,应考虑肾脏活检以明确诊断。
局限性
- 单例病例报告,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sézary syndrome is a rare aggressive leukemic variant of primary cutaneous T-cell lymphoma, typically presenting with erythroderma, lymphadenopathy, and an atypical clonal T-cell population. Though it often involves the spleen and liver, we report a case of Sézary syndrome with renal involvement that was treated successfully. Visceral involvement confers a poor prognosis requiring systemic treatment. The patient we describe was a 66-year-old man who was referred from Dermatology services for deteriorating kidney function. Polymerase chain reaction of genomic DNA from skin and kidney biopsies confirmed a clonal T-cell population matching a population isolated in peripheral blood. The patient was treated initially with alemtuzumab, which led to a significant improvement in kidney function, and he has subsequently received a successful allogeneic stem cell transplant. This case represents a rare cause of decreased kidney function and highlights the role of biopsy in patients with suspected Sézary syndrome.
引用
- Wickenden K, Graham-Brown MPM, Veitch D, et al. Sézary Syndrome Presenting With Renal Involvement. Am J Kidney Dis. 2018. PMID: 29941220. doi:10.1053/j.ajkd.2018.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。